Scarica l'app Stockscreener
1.17
4.88%
-0.06
Dopo l'orario di chiusura:
1.18
0.01
+0.85%
Precedente Chiudi:
$1.23
Aprire:
$1.24
Volume 24 ore:
3.95M
Relative Volume:
0.66
Capitalizzazione di mercato:
$751.69M
Reddito:
$196.12M
Utile/perdita netta:
$-69.59M
Rapporto P/E:
-11.22
EPS:
-0.1043
Flusso di cassa netto:
$-126.13M
1 W Prestazione:
-4.49%
1M Prestazione:
-9.30%
6M Prestazione:
-30.77%
1 anno Prestazione:
-4.88%
Intervallo 1D:
$1.17
$1.24
Intervallo di 1 settimana:
$1.17
$1.24
Portata 52W:
$1.04
$2.01
Geron Corp Stock (GERN) Company Profile
Nome
Geron Corp
Settore
Industria
Telefono
(650) 473-7700
Indirizzo
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Compare GERN vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.17 | 751.69M | 196.12M | -69.59M | -126.13M | -0.1043 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Ripresa | Goldman | Sell |
| 2025-05-08 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-02-27 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | Iniziato | H.C. Wainwright | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-09-09 | Iniziato | Leerink Partners | Outperform |
| 2024-04-30 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | Iniziato | TD Cowen | Buy |
| 2024-03-15 | Reiterato | Needham | Buy |
| 2023-09-12 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-03-28 | Iniziato | Goldman | Neutral |
| 2022-10-28 | Iniziato | Wedbush | Outperform |
| 2022-07-28 | Ripresa | B. Riley Securities | Buy |
| 2021-11-02 | Iniziato | Robert W. Baird | Outperform |
| 2021-02-18 | Ripresa | B. Riley Securities | Buy |
| 2020-08-03 | Iniziato | Stifel | Buy |
| 2019-11-19 | Ripresa | B. Riley FBR | Buy |
| 2019-09-03 | Iniziato | H.C. Wainwright | Buy |
| 2019-08-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-04-09 | Aggiornamento | Needham | Hold → Buy |
| 2019-01-31 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | Reiterato | FBR & Co. | Outperform |
| 2016-09-13 | Reiterato | FBR Capital | Outperform |
| 2015-12-07 | Reiterato | Piper Jaffray | Overweight |
| 2015-04-21 | Iniziato | Oppenheimer | Outperform |
| 2014-06-12 | Aggiornamento | MLV & Co | Hold → Buy |
| 2014-03-12 | Downgrade | MLV & Co | Buy → Hold |
| 2013-12-10 | Reiterato | MLV & Co | Buy |
| 2013-12-10 | Aggiornamento | Needham | Hold → Buy |
| 2013-11-08 | Reiterato | MLV & Co | Buy |
| 2013-10-16 | Iniziato | MLV & Co | Buy |
| 2012-08-30 | Iniziato | Stifel Nicolaus | Buy |
| 2012-06-28 | Iniziato | Needham | Hold |
Mostra tutto
Geron Corp Borsa (GERN) Ultime notizie
Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia - Yahoo Finance
In a 58-patient U.S. study, about 67% remained on Geron's treatment at six months. - Stock Titan
Geron Q2 2026 Earnings Call: Complete Transcript - Benzinga
Can Reblozyl Power Bristol Myers' Top-Line Growth Going Forward? - Zacks Investment Research
Shares replace cash fees for Geron (GERN) director Robert J. Spiegel, who acquired 6,351 shares. - Stock Titan
Law firm investigates Geron Corp officers for p... - Pluang
Law firm investigates Geron Corp over alleged m... - Pluang
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron CorporationGERN - Morningstar
Why Did GERN Stock Tumble 10% Pre-Market Today? - Stocktwits
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Sees RYTELO Revenue Near High End of 2026 Guidance as Community Use Expands - Yahoo Finance
GERN News | GERON CORP (NASDAQ:GERN) - ChartMill
Geron at cantor healthcare conference: RYTELO growth, profit path By Investing.com - Investing.com South Africa
Geron at cantor healthcare conference: RYTELO growth, profit path - Investing.com
Geron (GERN) Institutional Ownership 2026 - MarketBeat
Geron to Present at Upcoming Investor Conferences - Yahoo Finance
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? - Morningstar
Edmond DE Rothschild Holding S.A. Buys New Holdings in Geron Corporation $GERN - MarketBeat
Geron (GERN) After Earnings And New RYTELO Guidance Has The Valuation Story Changed - simplywall.st
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Corp.: Management's Plan Taking Shape As Competition Heats Up In Myelofibrosis - Seeking Alpha
RA Capital reports 66.5M-share Geron (GERN) position capped at 9.99% ownership - Stock Titan
Geron (NASDAQ:GERN) Stock Price Down 5.2%Here's Why - MarketBeat
GERN|Geron Corp|Price:1.530|Chg%:-0.040 - TradingKey
Geron CorporationCommon Stock (NQ: GERN - FinancialContent
Geron (NASDAQ:GERN) Shares Up 6.4%Here's What Happened - MarketBeat
Geron Corporation $GERN Stake Raised by Renaissance Technologies LLC - MarketBeat
Geron (GERN) Stock Looks Reasonable On Sales But Weak On Returns - Yahoo Finance
Geron (GERN) Back In Focus As Fresh Guidance And Earnings Test Its Undervalued Narrative - Yahoo Finance
Geron (GERN) Is Up 14.7% After Issuing First RYTELO Revenue Guide And Narrowing LossesHas The Bull Case Changed? - Yahoo Finance
Geron (GERN) Stock May Still Be Below Fair Value On Sales - simplywall.st
Geron Corporation Stock (GERN) Opinions on Recent Price Surge and Trial Updates - Quiver Quantitative
Janus Henderson Group PLC Raises Position in Geron Corporation $GERN - MarketBeat
Geron Stock Price Forecast. Should You Buy GERN? - StockInvest.us
Geron Corporation Stock (GERN) Opinions on Recent Price Surge and Trial Updates - quiverquant.com
State Street Corporation (GERN) discloses 5.6% beneficial stake in Geron - Stock Titan
HC Wainwright Issues Pessimistic Forecast for Geron Earnings - MarketBeat
Form 8K Geron Corporation For: 6 August By Investing.com - Investing.com South Africa
Form 8K Geron Corporation For: 6 August By Investing.com - Investing.com Nigeria
Is Geron Corp (GERN) on the Right Path After Q2 Earnings Report? - GuruFocus
Form 8K Geron Corporation For: 6 August By Investing.com - Investing.com India
Form 8K Geron Corporation For: 6 August By Investing.com - Investing.com Canada
Geron reports Q2 2026 RYTELO revenue $57.5M; net loss $16.7M; cash $327M - TradingView
Geron (NASDAQ:GERN) Posts Earnings Results, Misses Expectations By $0.01 EPS - marketbeat.com
Geron Corporation (GERN) stock price, news, quote and history - Yahoo Finance Singapore
GERON CORP 2026: Revenue $57.48M, EPS ($0.02) — 10-Q Summary - TradingView
[10-Q] GERON CORP Quarterly Earnings Report - Stock Titan
Geron earnings missed by $0.01, revenue topped estimates - Investing.com
Geron Corp Azioni (GERN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Geron Corp Azioni (GERN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER |
Feb 18 '26 |
Sale |
1.94 |
9,855 |
19,119 |
17,645 |
| JAMES ZIEGLER | Officer |
Dec 15 '25 |
Proposed Sale |
1.37 |
20,000 |
27,400 |
0 |
2.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):